Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
Is a |
Product containing sulfathiazole (medicinal product) |
false |
Inferred relationship |
Some |
|
|
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
Is a |
Product containing sulfacetamide (medicinal product) |
false |
Inferred relationship |
Some |
|
|
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
Is a |
Product containing sulfabenzamide (medicinal product) |
false |
Inferred relationship |
Some |
|
|
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sulfabenzamide (substance) |
false |
Inferred relationship |
Some |
|
|
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sulfacetamide (substance) |
false |
Inferred relationship |
Some |
|
|
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sulfathiazole (substance) |
false |
Inferred relationship |
Some |
|
|
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
Is a |
Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) |
false |
Inferred relationship |
Some |
|
|
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Baktericid |
false |
Inferred relationship |
Some |
|
|
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
Has manufactured dose form |
Vaginal dose form (dose form) |
false |
Inferred relationship |
Some |
|
|
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
Is a |
Product containing sulfacetamide in vaginal dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
Has manufactured dose form |
Vaginal cream |
false |
Inferred relationship |
Some |
|
|
sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|